Wildlife species show high SARS-CoV-2 exposure linked to human activity

FHS
July 31, 2024
2:27 am

Researchers found SARS-CoV-2 RNA in six wildlife species and higher seroprevalence in high human activity areas. Seven new human-to-animal transmission events of the Omicron variant were identified.

Study reviews the status of microbial succinic acid production

The current status and future perspectives on the successful industrialization of biobased succinic acid are discussed in a comprehensive review article in the peer-reviewed journal

June 30, 2023

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

What You Should Know: Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications

April 23, 2024

AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine – Pharmaceutical Technology

Share this article Parkinson’s disease is caused by a loss of nerve cells in part of the brain. Credit: Ocskay Mark via Shutterstock. US-based biotech

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.